Acalabrutinib
Obinutuzumab
Zanubrutinib
(Update) Acalabrutinib in CLL and MCL
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN Guidelines for Patients for CLL
Leukemia & Lymphoma Society
ASCO: COVID-19 Medical Resources